Clinical Trials


Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title Phase Last Update

An Open-label Phase 3 Study of Lutetium (Lu-177) Oxodotreotide Injection in Subjects with Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Phase 3

Last update: May 19

Phase 3 May 19

Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Phase 1

Last update: May 19

Phase 1 May 19

A IIT Study of Lu-177-DOTA-SNA040

Early Phase 1

Last update: May 19

Early Phase 1 May 19

Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Phase 2

Last update: May 18

Phase 2 May 18

A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants with Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 1

Last update: May 18

Phase 1 May 18

[F-18]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

N/A

Last update: May 15

N/A May 15

Observational Study on Lutetium (Lu-177) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer

N/A

Last update: May 15

N/A May 15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1

Last update: May 15

Phase 1 May 15

Flotufolastat F 18 PET in Men with Very Low PSA Recurrence

N/A

Last update: May 15

N/A May 15

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu-177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2

Last update: May 15

Phase 2 May 15